
Newsletter
Promoter: | InsideStockSecrets | Paying Party: | UNKNOWN |
Stocks covered: | Compensation: | Avg $ Volume for Period: |
CIHN | No compensation | UNKNOWN |
Max Profit: 25.00 % | Gain at close: 0.00 % |

CIHN ~ 1st Stem Cell Patent & Treatment Underway News! Good Morning Fellow Traders,?
CIHN's fresh off the press must see news: New Management of CIHN Confirms Its First Stem Cell Patient and Treatment Being Performed by Dr. Liriano, With the Input of Dr. Gonzalez and Cells From Davinci Labs, CIHN Announces a Wide Variety of New Potential Patients to Come
Caribbean International Holdings, Inc. (CIHN) announces and confirms its first stem cell procedure to take place in Santiago, Dominican Republic, by Dr. Liriano with the input of Dr. Gonzalez. CIHN and its new management is excited to announce its first stem cell patient and treatment being performed at Dr. Liriano's facility http://bellaforma.com.do. This new patient is a 49-year-old male that is looking forward to his stem cell treatment in order to help improve overall wellness and minimize chronic back pain. Furthermore, this new patient and treatment is scheduled to take place on November 10th, 2014.
The new management of CIHN, along with Dr. Gonzalez has been in communication with a wide variety of new potential patients pursuing multiple different stem cell treatment options. CIHN is currently processing these potential patients' medical records and history in order to allow both Dr. Liriano and Dr. Gonzalez to determine treatments best suited for the individual. CIHN looks forward to working with and treating several of these potential patients in the near term and will keep the market updated in regards to its progress. The company appreciates the patience from its shareholders as it continues to create a presence in the rapidly emerging stem cell industry. CIHN has scheduled a meeting with both Dr. Liriano and Dr. Gonzalez on November 11th, 2014 to go over the completed procedure and to discuss the future growth of CIHN. This includes outlining the future logistics and procedures to streamline future patients. CIHN CEO, Mark Farber MD, PhD, MS received degrees from Brown University and SUNY; During his time at Harvard Medical School he developed bioreactor designs for stem cell based tissue engineered heart valves. From YahooFinance
CIHN is doing just as we expecting, releasing one of their many hinted news based off last week's news. We expect to see some major announcements in the near future on the following:
Applied to FINRA for company name change to Biostem Technologies. Private investment group, J3 Financial has acquired a controlling interest in CIHN and has done a tremendous amount of restructuring in order to start aggressively build this emerging company. New corporate website is being developed and looks to be released by mid-November 2014. www.biostemtech.com Board has had many progressive meetings with Rafael Gonzalez, PhD and plans on unveiling more about the positive events near term. Rafael Gonzalez has extensive knowledge in stem cell research and development as well as implementing standard operating procedures. In addition, to his experience in stem cell culture and biology from humane embryonic, pre-natal and adult sources, he has extensive knowledge in degenerative disorders involiving the spinal cord. Keep in mind CIHN's short term technical breakout is .0106 cents or roughly 200% to 300% short term move from its current levels. CIHN's mid-term breakout and resistance is .045 cents which is over 1000% breakout return potential from its current range. ? If you got this Email you've been successfully placed on our Premium Newsletter for FREE as a New Premium Member in order to get our Next Featured Pick before the Rest of the herd. For the new members who just joined us, welcome.
|
Thank you, we have your best interest in view... Happy Trading to our members, InsideStockSecrets Team |
Disclaimer/General Notice: This disclaimer is to be read and fully understood before using our site or joining our email list. By viewing or using Insidestocksecrets.com (here after referred to as ISS) you hereby fully agree to our Disclaimer and following terms http://insidestocksecrets.com/legal-disclaimer/ Never invest into a stock discussed on our website or the ISS newsletter unless you can afford to lose your entire investment. ISS is not an investment advisor and is not making any target prices or financial projections. Always do your own research and make your own investment decisions. This email is meant for informational and educational purposes only and does not provide investment advice. ISS never recommends to buy or sell any stock. ISS has not been compensated for investor communications on nor does ISS own any shares in CIHN This email is not a solicitation or recommendation to buy, sell, or hold securities. Never make investment decisions and never invest based on anything ISS says…Forward-looking-statements (FLS): The Private-Securities-Litigation-Reform-Act…of…1995 provides investors a 'safe harbor' in regard to FLS. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance that are not statements of historical fact may be FLS. FLS are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. FLS in this action may be identified through use of words such as "projects", "foresee", "expects", "will", "anticipates", "estimates", "believes", "understands", or that by statements indicating certain actions "may", "could", or "might" occur. Understand there is no guarantee past performance will be indicative of future results. |
©2013 ISS All Rights Reserved. ISS 3109 Grand Ave, Miami, FL 33133 USA.